Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


01.04.2019

1 Am J Surg
1 Ann Surg Oncol
6 BMC Cancer
1 BMC Gastroenterol
1 Cancer Lett
2 Cancer Res
1 Dig Dis
1 Dis Colon Rectum
1 Gastrointest Endosc
1 Gut
1 Int J Colorectal Dis
1 Int J Oncol
1 J Natl Cancer Inst
6 J Surg Oncol
1 Lancet Gastroenterol Hepatol
1 Oncogene
1 Oncology
3 PLoS One
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. JIANG B, Ofshteyn A, Idrees JJ, Giglia M, et al
    Total abdominal colectomy is cost-effective in treating colorectal cancer in patients with genetically diagnosed Lynch Syndrome.
    Am J Surg. 2019 Mar 16. pii: S0002-9610(19)30232.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. HUANG SH, Tsai WS, You JF, Hung HY, et al
    Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis.
    Ann Surg Oncol. 2019 Mar 26. pii: 10.1245/s10434-019-07184.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. ZHENG B, Wang X, Wei M, Wang Q, et al
    First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2019;19:280.
    PubMed     Text format     Abstract available

  4. JANG M, Kwon Y, Kim H, Kim H, et al
    Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study.
    BMC Cancer. 2018;18:1218.
    PubMed     Text format     Abstract available

  5. SANDBERG TP, Stuart MPME, Oosting J, Tollenaar RAEM, et al
    Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
    BMC Cancer. 2019;19:284.
    PubMed     Text format     Abstract available

  6. BOWLES EJA, Yu O, Ziebell R, Chen L, et al
    Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study.
    BMC Cancer. 2019;19:270.
    PubMed     Text format     Abstract available

  7. XU Y, Yang X, Gao D, Yang L, et al
    Dihomo-gamma-linolenic acid inhibits xenograft tumor growth in mice bearing shRNA-transfected HCA-7 cells targeting delta-5-desaturase.
    BMC Cancer. 2018;18:1268.
    PubMed     Text format     Abstract available

  8. LIN Z, Liu J, Peng L, Zhang D, et al
    Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report.
    BMC Cancer. 2018;18:1253.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  9. XIE MZ, Li JL, Cai ZM, Li KZ, et al
    Impact of primary colorectal Cancer location on the KRAS status and its prognostic value.
    BMC Gastroenterol. 2019;19:46.
    PubMed     Text format     Abstract available


    Cancer Lett

  10. TREMBLE LF, O'Brien MA, Forde PF, Soden DM, et al
    ICOS activation in combination with electrochemotherapy generates effective anti-cancer immunological responses in murine models of primary, secondary and metastatic disease.
    Cancer Lett. 2018;420:109-115.
    PubMed     Text format     Abstract available


    Cancer Res

  11. CASTLE PE
    Charting the Future of Cancer Health Disparities Research-Letter.
    Cancer Res. 2018;78:1883-1885.
    PubMed     Text format    

  12. SCHWAB A, Siddiqui A, Vazakidou ME, Napoli F, et al
    Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells.
    Cancer Res. 2018;78:1604-1618.
    PubMed     Text format     Abstract available


    Dig Dis

  13. WANG D, Zhang J, Li Z, Han J, et al
    Upregulation of Fibroblast Growth Factor 19 Is Associated with the Initiation of Colorectal Adenoma.
    Dig Dis. 2019;37:214-225.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  14. WANIS KN, Maleyeff L, VanKoughnett JM, Colquhoun P, et al
    Health and Economic Impact of Intensive Surveillance for Distant Recurrence After Curative Treatment of Colon Cancer: A Mathematical Modeling Study.
    Dis Colon Rectum. 2019 Mar 21. doi: 10.1097/DCR.0000000000001364.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  15. BURR NE, Morris EJA, Rutter MD, Valori R, et al
    Predictions of an individual's chance of postcolonoscopy colorectal cancer gives false reassurance both within and outside the United States.
    Gastrointest Endosc. 2019;89:896.
    PubMed     Text format    


    Gut

  16. TIE J, Cohen JD, Wang Y, Li L, et al
    Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.
    Gut. 2019;68:663-671.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  17. ROMITI A, Roberto M, Marchetti P, Di Cerbo A, et al
    Study of histopathologic parameters to define the prognosis of stage II colon cancer.
    Int J Colorectal Dis. 2019 Mar 26. pii: 10.1007/s00384-019-03279.
    PubMed     Text format     Abstract available


    Int J Oncol

  18. LEI X, Deng L, Liu D, Liao S, et al
    ARHGEF7 promotes metastasis of colorectal adenocarcinoma by regulating the motility of cancer cells.
    Int J Oncol. 2018;53:1980-1996.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  19. HAWKINS ML, Blackburn BE, Rowe K, Snyder J, et al
    Endocrine and Metabolic Diseases among Colorectal Cancer Survivors in a Population-Based Cohort.
    J Natl Cancer Inst. 2019 Mar 27. pii: 5421169. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Surg Oncol

  20. MARGONIS GA, Kreis ME, Wolfgang CL, Weiss MJ, et al
    Mutation status and surgical selection.
    J Surg Oncol. 2019;119:616-622.
    PubMed     Text format     Abstract available

  21. KAWAGUCHI Y, Lillemoe HA, Vauthey JN
    Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy.
    J Surg Oncol. 2019;119:594-603.
    PubMed     Text format     Abstract available

  22. LINECKER M, Kuemmerli C, Clavien PA, Petrowsky H, et al
    Dealing with insufficient liver remnant: Associating liver partition and portal vein ligation for staged hepatectomy.
    J Surg Oncol. 2019;119:604-612.
    PubMed     Text format     Abstract available

  23. DAY RW, Aloia TA
    Enhanced recovery in liver surgery.
    J Surg Oncol. 2019;119:660-666.
    PubMed     Text format     Abstract available

  24. PHILLIPS JD, Hasson RM
    Surgical management of colorectal lung metastases.
    J Surg Oncol. 2019;119:629-635.
    PubMed     Text format     Abstract available

  25. KRELL RW, D'Angelica MI
    Treatment sequencing for simultaneous colorectal liver metastases.
    J Surg Oncol. 2019;119:583-593.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  26. GLYNNE-JONES R
    Watch and wait in rectal cancer: is it time to subclassify cT3?
    Lancet Gastroenterol Hepatol. 2018;3:814-815.
    PubMed     Text format    


    Oncogene

  27. CLARKE PA, Roe T, Swabey K, Hobbs SM, et al
    Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer.
    Oncogene. 2019 Mar 25. pii: 10.1038/s41388-019-0780.
    PubMed     Text format     Abstract available


    Oncology

  28. TAMPAKIS A, Tampaki EC, Nonni A, Droeser R, et al
    Nectin-1 Expression in Colorectal Cancer: Is There a Group of Patients with High Risk for Early Disease Recurrence?
    Oncology. 2019 Mar 27:1-8. doi: 10.1159/000499569.
    PubMed     Text format     Abstract available


    PLoS One

  29. STOFFEL ST, Yang J, Vlaev I, von Wagner C, et al
    Testing the decoy effect to increase interest in colorectal cancer screening.
    PLoS One. 2019;14:e0213668.
    PubMed     Text format     Abstract available

  30. KIM EJ, Woo HS, Cho JH, Sym SJ, et al
    Early experience with Watson for oncology in Korean patients with colorectal cancer.
    PLoS One. 2019;14:e0213640.
    PubMed     Text format     Abstract available

  31. INABA S, Hinohara A, Tachibana M, Tsujikawa K, et al
    Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential.
    PLoS One. 2018;13:e0205467.
    PubMed     Text format     Abstract available


    World J Surg

  32. SIMILLIS C, Kalakouti E, Afxentiou T, Kontovounisios C, et al
    Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.
    World J Surg. 2019 Mar 22. pii: 10.1007/s00268-019-04984.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: